¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø 2019 The 6th Esophageal Cancer Symposium : 2019-11-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø 2019 The 6th Esophageal Cancer Symposium : 2019-11-16
±³À°ÀÏÀÚ : 2019-11-16
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : 2019 The 6th Esophageal Cancer Symposium
ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÈäºÎ¿Ü°ú  
´ã´çÀÚ : ¹ÚÁÖ¿¬
¿¬¶ôó : 02-3410-3489  
À̸ÞÀÏ : sd000.park@samsung.com      
±³À°Á¾·ù : ±âŸ      
Âü¼®¿¹»óÀοø : 180¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï-(Àü°øÀÇ,°£È£»ç,±âŸ)20,000 /(°³¿øÀÇ,Àü¹®ÀÇ)30,000 ; ´çÀϵî·Ï-(Àü°øÀÇ,°£È£»ç,±âŸ)30,000 /(°³¿øÀÇ,Àü¹®ÀÇ)40,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 08:30~08:50 1. Esophageal cancer staging: past, present, and future  ÀÌÈ£¼®(ºÎ»ê´ëÇб³º´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 08:50~09:10 2. Minimally invasive esophagectomy  °­Ã¢Çö(¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 09:10~09:20 Discussant : Total MIE vs. Hybrid MIE  ±è¿ëÈñ(¼­¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 09:20~09:40 3. Neoadjuvant therapy for esophageal cancer  ¿Àµ¿·Ä(»ï¼º¼­¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 09:40~09:50 Discussant : Optimal regimen of neoadjuvant CCRT  ±èÁ¾ÈÆ(¼­¿ï¾Æ»êº´¿ø ¹æ»ç¼±Á¾¾çÇаú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 09:50~10:10 4. Adjuvant therapy for esophageal cancer  ¼±Á¾¹«(»ï¼º¼­¿ïº´¿ø Á¾¾ç³»°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 10:10~10:20 Discussant : Why, Whom, and How?  ¹Ú¼÷·Ã(¼­¿ï¾Æ»êº´¿ø Á¾¾ç³»°ú) 
È޽Ġ11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 10:20~10:40 Coffee break  () 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 10:40~10:55 1. Endoscopic treatment for early superficial esophageal cancer  Á¤ÈÆ¿ë(¼­¿ï¾Æ»êº´¿ø ¼ÒÈ­±â³»°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 10:55~11:05 Discussant : ASSURE trial  ±èÈ«°ü(»ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 11:05~11:20 2. Intraoperative fluorescence imaging during esophagectomy  ±èÇö±¸(°í·Á´ëÇб³ ±¸·Îº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 11:20~11:35 3. The role of modern RT technology in treatment of esophageal cancer  ¹®¼ºÈ£(±¹¸³¾Ï¼¾ÅÍ ¹æ»ç¼±Á¾¾çÇаú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 11:35~11:50 4. Immunotherapy in locally advanced or advanced esophageal cancer  Á¶º´Ã¶(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø Á¾¾ç³»°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 11:50~12:00 Q and A  () 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 12:00~12:30 Current status and future perspective of minimally invasive esophagectomy  Yuko Kitagawa(Keio University) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 12:30~12:40 Q and A  () 
½Ä»ç 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 12:40~13:30 Lunch  () 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 13:30~13:45 1. Chylous leak after esophagectomy  ¹Ú¼º¿ë(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø ÈäºÎ¿Ü°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 13:45~13:55 Discussant: thoracic duct embolization  Çã¼¼¹ü(¼­¿ï´ëÇб³º´¿ø ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 13:55~14:10 2. Endoluminal treatment for esophageal leak  ¹Î¾ç¿ø(»ï¼º¼­¿ïº´¿ø ¼ÒÈ­±â³»°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 14:10~14:25 3. Fistula between the esophagus and adjacent vital structure  Á¶¼®±â(ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 14:25~14:35 Discussant : challenging case review  Á¶ÀçÀÏ(»ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 14:35~14:45 Q and A  () 
È޽Ġ11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 14:45~15:05 Coffee break  () 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 15:05~15:25 1. Quality of life in esophageal cancer patient: Based on clinical experiences of 3,000 esophagectomy cases for esophageal cancer in SMC  ½É¿µ¸ñ(»ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 15:25~15:40 2. Reflux after esophagectomy  ½Åö¹Î(ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 15:40~15:55 3. Stricture after esophageal reconstruction : management and prevention  ±èÇü·Ä(¼­¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 15:55~16:10 4. Delayed gastric emptying: management and prevention  ¾çÈñö(±¹¸³¾Ï¼¾ÅÍ ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 16:10~16:25 5. Optimal pyloric procedure  ±èµµÈÆ(ÃæºÏ´ëÇб³º´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 16:25~16:45 6. Current trends in esophageal cancer management - 2018 ISDE review  ÀüÀçÇö(ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú) 
Åä·Ð 11-16 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç 16:45~17:00 Q and A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø 2019 The 6th Esophageal Cancer Symposium : 2019-11-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦69Â÷ ´ëÇÑÅëÁõÇÐȸ Çмú´ëȸ : 2019-11-16
´ÙÀ½±Û ´ëÇÑ¿¹¹æÀÇÇÐȸ Á¦4±â Áö¿ª»çȸ °øÁߺ¸°Ç ÃÖ°í¸®´õ°úÁ¤(13): °Ç°­µµ½Ã ÇöȲ°ú Àü¸Á : 2019-11-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20850 ±¤ÁÖ 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 4 2024-05-27
20849 ¼­¿ï ´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2024 (PB-SS) : 2024-06-22 0 8 2024-05-27
20848 ¼­¿ï Á¦26Â÷ ¼­¿ï¾Æ»êº´¿ø È£Èí±â³»°ú ¿¬¼ö°­Á : °áÇÙ°ú ºñ°áÇÙÇ×»ê±Õ ÆóÁúȯÀÇ ÃÖ½ÅÁö°ß : 2024-06-22 0 2 2024-05-27
20847 ¼­¿ï Á¦3ȸ Severance Orthopaedic Review(¼¼ºê¶õ½º ±Ù°ñ°Ý ¿¬¼ö°­ÁÂ) : 2024-06-22 0 5 2024-05-27
20846 ¼­¿ï (¿Â¶óÀÎ)2024³â ¼­´ë¹®±¸ÀÇ»çȸ ¿Â¶óÀÎÇмú´ëȸ : 2024-06-22 0 3 2024-05-27
20845 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22 0 7 2024-05-27
20844 ´ë±¸ 2024³â Á¦ 23ȸ ´ëÇѵΰ³¾È¸é¼ºÇü¿Ü°úÇÐȸ Ãá°è½ÉÆ÷Áö¾ö : 2024-06-22 0 3 2024-05-27
20843 ¼­¿ï µ¿ÀÛ±¸ÀÇ»çȸ ÀÇÇÐ ¿¬¼ö±³À°(¸¸¼ºÁúȯ, Å»¸ð¿Í ÇǺΰü¸®, »ý¼ºÇü AI Æ®·»µå¿Í ÀÇ·á, ÀÇ·áºÐÀï) : 2024-06-22 0 3 2024-05-27
20842 ¼­¿ï (¿Â¶óÀÎ) °øȲ¹üºÒ¾ÈÀå¾Ö Ä¡·áÀÇ ½ÉÃþÀû Á¢±Ù : 2024-06-22 0 3 2024-05-27
20841 °æ±â 2024³â ´ëÇѳëÀκñ´¢ÀÇÇÐȸ Á¦7Â÷ Á¤±âÇмú´ëȸ : 2024-06-22 0 3 2024-05-27
20840 ¼­¿ï (¿Â¶óÀÎ) Á¦34Â÷ ´ëÇѼҾÆÀÓ»ó¸é¿ªÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 6 2024-05-27
20839 ´ë±¸ 2024 ´ë±¸±¤¿ª½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 2 2024-05-27
20838 ¼­¿ï »ï¼º¼­¿ïº´¿ø The 21th SMC STROKE SYMPOSIUM, 2024 : 2024-06-22 0 3 2024-05-27
20837 ±¤ÁÖ 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-06-21 0 2 2024-05-27
20836 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(2ÀÏÂ÷) : 2024-06-21 0 3 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷